Intra-Cellular Therapies Inc (DELISTED) (ITCI:DL)
131.87
0.00 (0.00%)
USD |
NASDAQ |
Apr 04, 16:00
Intra-Cellular Therapies Profit Margin (Quarterly): -8.48% for Dec. 31, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.47% |
| Moderna, Inc. | -19.68% |
| Eli Lilly & Co. | 31.72% |
| AbbVie, Inc. | 1.13% |
| Sage Therapeutics Inc (DELISTED) | -156.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.07% |
| Return on Assets | -6.80% |
| Return on Invested Capital | -8.07% |
| Gross Profit Margin (Quarterly) | 89.76% |
| Operating Margin (Quarterly) | -14.66% |
| Return on Net Operating Assets | -42.63% |